Paper

Rapid Whole Genome Sequencing Decreases Morbidity and Healthcare Cost of Hospitalized Infants

Ding, Yan, Clark, Michelle, Kingsmore, Stephen, Chowdhury, Shimul, Veeraraghavan, Narayanan, Investigators, Rcigm, Friedman, Jennifer, Benson, Wendy, Bainbridge, Matthew, Gold, Jeffrey, Kaplan, Robert, Hildreth, Amber, Kronick, Richard, Sweeney, Nathaly, Farnaes, Lauge, Nahas, Shareef, Cakici, Julie, Dimmock, David

2018

Overview

BACKGROUND: Genetic disorders are a leading cause of morbidity and mortality in infants. Rapid Whole Genome Sequencing (rWGS) can diagnose genetic disorders in time to change acute medical or surgical management (clinical utility) and improve outcomes in acutely ill infants. METHODS: Retrospective cohort study of acutely ill inpatient infants in a regional childrens hospital from July 2016-March 2017. Forty-two families received rWGS for etiologic diagnosis of genetic disorders. Probands received standard genetic testing as clinically indicated. Primary end-points were rate of diagnosis, clinical utility, and healthcare utilization. The latter was modelled in six infants by comparing actual utilization with matched historical controls and/or counterfactual utilization had rWGS been performed at different time points. FINDINGS: The diagnostic sensitivity was 43% (eighteen of 42 infants) for rWGS and 10% (four of 42 infants) for standard of care (P=.0005). The rate of clinical utility for rWGS (31%, thirteen of 42 infants) was significantly greater than for standard of care (2%, one of 42; P=.0015). Eleven (26%) infants with diagnostic rWGS avoided morbidity, one had 43% reduction in likelihood of mortality, and one started palliative care. In six of the eleven infants, the changes in management reduced inpatient cost by $800, 000 to $2,000,000. DISCUSSION: These findings replicate a prior study of the clinical utility of rWGS in acutely ill inpatient infants, and demonstrate improved outcomes and net healthcare savings. rWGS merits consideration as a first tier test in this setting. Clinical trial registration ID #NCT02917460

• Publisher: Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
• Subject: Clinical Trials / Cost control / Diagnosis / Genetic disorders / Genetic screening / Genomes / Infants / Morbidity / Mortality